Delayed B cell repopulation after rituximab treatment in multiple sclerosis patients with expanded adaptive natural killer cells

BACKGROUND AND PURPOSE: The aim was to evaluate whether adaptive NKG2C+ natural killer (NK) cells, characterized by enhanced antibody‐dependent cell cytotoxicity (ADCC), may influence time to B cell repopulation after rituximab treatment in multiple sclerosis (MS) patients. METHODS: This was a prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreira, Antía, Munteis, Elvira, Vera, Andrea, Macías Gómez, Adrián, Bertrán Recasens, Bernat, Rubio Pérez, Miguel Ángel, Llop, Mireia, Martínez‐Rodríguez, Jose E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Multiple Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310749/
https://www.ncbi.nlm.nih.gov/pubmed/35247022
http://dx.doi.org/10.1111/ene.15312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310749/
https://www.ncbi.nlm.nih.gov/pubmed/35247022
http://dx.doi.org/10.1111/ene.15312

Ejemplares similares